Imspex Diagnostics Ltd. – Trademark Portfolio
Entity Type: 16
Imspex Diagnostics Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FLUIDSPEC, BREATHSPEC, and IMSPEXMEDICAL. The owner is based in Rhondda Cynon Taf.
GTI Suite, Ty Menter
Navigation Park, Abercynon
Rhondda Cynon Taf CF454SN , GB
Showing of trademarks Trademarks
Trademark Classifications
Imspex Diagnostics Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Imspex Diagnostics Ltd. have?
Imspex Diagnostics Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Imspex Diagnostics Ltd. file in?
Imspex Diagnostics Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Imspex Diagnostics Ltd.'s most well-known trademarks?
Imspex Diagnostics Ltd.'s registered trademark portfolio includes well-known marks such as FLUIDSPEC, BREATHSPEC, and IMSPEXMEDICAL. These are among 3 currently registered trademarks in the portfolio.
What is Imspex Diagnostics Ltd.'s trademark registration success rate?
Imspex Diagnostics Ltd. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.